Research Guide · 10 min read

What Is a Certificate of Analysis for Research Peptides?

What is a Certificate of Analysis?

A Certificate of Analysis (CoA) is a formal document issued by a manufacturer or independent testing laboratory that certifies a specific batch of material meets defined quality specifications. For research peptides, the CoA documents analytical test results including identity confirmation, purity determination, and physical characteristics of the compound under examination [1].

Unlike a generic product specification sheet, a CoA is batch-specific: it reports the results from the exact lot you are receiving, not a theoretical average. A standard CoA includes the peptide name, sequence, batch or lot number, purity percentage, analytical methods used (such as HPLC and mass spectrometry), storage conditions, and the issuing laboratory's credentials [2].

Why CoAs matter for research integrity

Peptides are used as precision tools in biochemical assays, receptor binding studies, cell signalling research and preclinical models. The scientific integrity of these experiments depends on knowing — with documented certainty — what compound is actually being studied [3].

Impurity profiles vary between synthesis batches, introducing variability across experiments. Consistent ≥99% purity reduces batch-to-batch variation, supporting longitudinal studies and cross-laboratory comparisons [4]. As little as 1–2% of contaminating material can introduce significant confounding variables in sensitive receptor-binding or cell-signalling assays — the kind of impurities that, if left undocumented, quietly invalidate weeks of laboratory work [5].

The anatomy of a peptide CoA

A properly issued CoA contains a defined set of fields that together create a complete analytical fingerprint of the batch. According to published guidance, the following sections are considered essential [1][6]:

• Batch / lot number — uniquely identifies the synthesis run the certificate refers to.
• Compound name and sequence — the chemical name and (for peptides) the amino-acid sequence.
• Molecular formula and molecular weight — used to verify identity against mass spectrometry data.
• HPLC purity result — typically reported as a percentage of the main peak area.
• Mass spectrometry result — observed mass alongside the theoretical mass for direct comparison.
• Testing date — when the analysis was actually performed.
• Issuing laboratory — the name and credentials of the lab that produced the certificate.
• Verification key or QR code — allowing the certificate to be cross-checked on the laboratory's own platform.

If any of these fields are missing or generic, the document does not function as a true CoA — it is closer to a marketing sheet.

HPLC and mass spectrometry explained

Two analytical methods form the backbone of every credible peptide CoA. They answer two different but complementary questions [4][7]:

High-Performance Liquid Chromatography (HPLC)

HPLC separates the components of a sample by passing it through a column under high pressure. Reversed-phase HPLC with C18 columns and UV detection at 214–220 nm is the standard for peptide purity assessment [8]. The technique calculates purity as the main peak area divided by total peak area — answering the question: how much of what is in the vial is the target compound?

Mass Spectrometry (MS or LC-MS)

Mass spectrometry confirms the molecular weight of the compound by measuring its mass-to-charge ratio after ionisation. Published guidelines establish mass spectrometry as the definitive identity test for synthetic peptides [1]. The resulting spectrum shows the molecular ion peak, which can be directly compared against the theoretical mass calculated from the peptide's elemental composition. MS answers the question: is this molecule actually the compound we expected?

Purity standards: what ≥99% really means

For most research applications, ≥98% purity (measured by HPLC) is considered the research-grade standard. Premium suppliers target ≥99% purity, with impurities below 1%, including truncated sequences from incomplete synthesis, deletion variants, dimers, or oxidation products [8][9].

The remaining fraction — even when small — is not inert. It typically consists of synthesis by-products that may share structural similarities with the target peptide and can therefore engage the same receptors or pathways. This is precisely why ≥99% purity has become the benchmark for peptides used in receptor-pharmacology, metabolic signalling and preclinical model research.

Third-party vs in-house testing

Not all CoAs carry the same evidential weight. A document produced by the same company that synthesised the peptide is fundamentally different from one issued by an independent laboratory with no commercial relationship to the supplier.

Third-party CoAs from accredited laboratories — particularly those holding ISO/IEC 17025 accreditation, the international standard for testing-laboratory competence — carry significantly more weight because they are independent from the supplier [10][11]. In-house testing is acceptable when proper QC facilities exist, but third-party verification provides an additional layer of assurance that the data is genuine and the methods are properly validated.

How RETA UK verifies every batch

At RETA UK, every batch of research peptides arriving at our UK warehouse is sent for independent third-party analysis before any unit is offered for sale. Our verification workflow is built around three principles:

• Batch testing on arrival — samples are sealed and dispatched for independent analysis the moment a new batch lands at the warehouse.
• Accredited third-party laboratories — we partner with internationally recognised laboratories including Janoshik Analytical (Czech Republic) and Analiza Białek (Poland) for verification work.
• HPLC + mass spectrometry verification — every compound is profiled using HPLC for percentage purity and mass spectrometry for unambiguous identity confirmation.

Once the laboratory returns its certificate, the verified CoA is published on our Quality Testing page — so the documentation researchers see always corresponds to the batch currently in circulation, never historical data from a previous lot.

Red flags to watch for

Not every document labelled "Certificate of Analysis" qualifies as one. The following warning signs should prompt closer scrutiny before relying on a peptide for research [9][12]:

• No batch or lot number — a generic CoA that could in theory accompany any unit ever shipped tells you nothing about your specific vial.
• "Representative sample" certificates — these report on a sample that may have no relationship to the unit you received.
• HPLC without an actual chromatogram — a purity percentage without a visible peak profile is scientifically insufficient.
• HPLC only, no mass spectrometry — purity without identity confirmation leaves the most important question unanswered.
• No verification key or laboratory contact — a certificate that cannot be cross-checked independently is unverifiable.
• Identical CoAs across multiple batches — strongly suggests reuse rather than batch-specific testing.

How to verify your peptide's CoA

Every batch RETA UK supplies has its verified CoA published openly. To check the certificate for a peptide you are working with:

1. Visit the RETA UK Quality Testing page.
2. Search the table by product name, laboratory or testing date.
3. Click View Certificate to see the verified HPLC and mass spectrometry data.
4. If you would like written confirmation of the batch attached to your specific order, contact us through our contact form with your order number and we will reply with the corresponding certificate.

Independent certificates issued by Janoshik Analytical can also be cross-verified directly on the laboratory's own platform at janoshik.com/verify using the unique key printed on each report.